Plant-Based Biologics Market
- 2026 年市場規模
- USD 23.7 Mn
- 2033 年預估規模
- USD 30.0 Mn
- 年複合成長率 CAGR
- 3.4%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Plant-Based Biologics Market, By Product Type (Monoclonal Antibodies, Alpha Interferon, Glucocerebrosidase, Vaccines, Others), By Source Type (Carrot, Tobacco Leaves, Rice Seeds, Alfalfa, Others), By Disease Indication (Gaucher Disease, Tooth Decay, Hepatitis, Lymphoma, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Plant-based biologics are biologic drugs that are manufactured by using plant molecular farming. They are also known as plant-made biologics (PMB). The applications and advantages of plant-based biologics have stretched beyond the traditional boundaries of vaccines and therapeutic proteins. For instance, bacterial colicins derived from plants in 2015 were recently proven effective as food additives for controlling pathogenic bacteria in food products. These colicins are highly effective (even when used in lower concentrations) to fight against all the pathogenic Escherichia coli strains that cause food poisoning. Moreover, it costs around US$ 1.00 for manufacturing one gram of purified colicins, which is commercially viable.
Market Dynamics
The increasing demand for biologics for various chronic diseases and rising investments in R&D for the production of biologics are expected to contribute significantly to the growth of plant-based biologics market. For instance, according to the Biotechnology Innovation Organization (BIO) 2015, over 250 biologic therapies and vaccines have changed the lives of hundreds of millions of patients. Moreover, according to the same source, over 900 biologics are currently (2018) under the stage of development for over 100 diseases in the U.S. Furthermore, according to the Pharmaceutical Research and Manufacturers of America (PhRMA), 2016, member companies invested around US$ 58.8 billion in research and development in 2015, of which, majority of the investments was made by all the biopharmaceutical companies in the U.S. for the treatment of rare diseases.
Many biopharmaceutical companies are focused on developing plant-made pharmaceuticals using various plants such as tobacco, duckweed, moss, alfalfa, and other plants, which is expected to propel growth of the plant-based biologics market. For instance, in September 2015, LeafBio, Inc., the commercial partner of Mapp Biopharmaceutical, Inc. (Mapp), was granted fast track designation by the U.S. Food and Drug Administration (FDA) for their plant-made drug ZMapp for the treatment of Ebola virus disease.
However, stringent regulatory guidelines for the production of plant-based biologics is one of the major factors restraining growth of the plant-based biologics market. Moreover, concern regarding contamination and environmental risks is another factor restraining growth of the market.
Key features of the study
• This report provides in-depth analysis of the global plant-based biologics market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2026-2033, considering 2025 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles key players in the global plant-based biologics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include Leaf Expression Systems, Zea Biosciences, Planet Biotechnology Inc., InVitria, PlantForm Corporation, IBIO, Inc., Mapp Biopharmaceutical, Inc., Pfizer Inc., Ventria Bioscience Inc., Medicago Inc., Eleva GmbH, Kentucky Bioprocessing, LLC, Solarvest Bioenergy Inc., and Byondis B.V.
• Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global plant-based biologics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for plant-based biologics market, research and consulting firms, new entrants, and financial analysts.
Market Segmentation
• By Product Type (Revenue, USD Mn, 2021-2033)
o Monoclonal Antibodies
o Alpha Interferon
o Glucocerebrosidase
o Vaccines
o Others
• By Source Type (Revenue, USD Mn, 2021-2033)
o Carrot
o Tobacco Leaves
o Rice Seeds
o Alfalfa
o Others
• By Disease Indication (Revenue, USD Mn, 2021-2033)
o Gaucher Disease
o Tooth Decay
o Hepatitis
o Lymphoma
o Others
• By Region (Revenue, USD Mn, 2021-2033)
o North America
U.S.
Canada
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
South Africa
Central Africa
North Africa
• Key Players
o Leaf Expression Systems
o Zea Biosciences
o Planet Biotechnology Inc.
o InVitria
o PlantForm Corporation
o IBIO, Inc.
o Mapp Biopharmaceutical, Inc.
o Pfizer Inc.
o Ventria Bioscience Inc.
o Medicago Inc.
o Eleva GmbH
o Kentucky Bioprocessing, LLC
o Solarvest Bioenergy Inc.
o Byondis B.V.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Product Type
Market Snapshot, By Source Type
Market Snapshot, By Disease Indication
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Product Approval
o Collaboration/Merge/Acquisition
o Regulatory Landscape
o PEST Analysis
o Porter’s Five Forces Analysis
o Epidemiology
o Robust Pipeline Analysis
4. Global Plant-Based Biologics Market, By Product Type, 2021 – 2033, (USD Million)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022– 2033
Segment Trends
o Monoclonal Antibodies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
o Alpha Interferon
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
o Glucocerebrosidase
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
o Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
5. Global Plant-Based Biologics Market, By Source Type, 2021 – 2033, (USD Million)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022– 2033
Segment Trends
o Carrot
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
o Tobacco Leaves
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
o Rice Seeds
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
o Alfalfa
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
6. Global Plant-Based Biologics Market, By Disease Indication, 2021 – 2033, (USD Million)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022– 2033
Segment Trends
o Gaucher Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
o Tooth Decay
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
o Hepatitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
o Lymphoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
7. Global Plant-Based Biologics Market, By Region, 2021 – 2033, (USD Million)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022–2033
Regional Trends
o North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
o GCC
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
o North Africa
o Central Africa
o South Africa
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
o Company Profile
Leaf Expression Systems
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Zea Biosciences
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Planet Biotechnology Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
InVitria
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
PlantForm Corporation
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
IBIO, Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Mapp Biopharmaceutical, Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Pfizer Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Ventria Bioscience Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Medicago Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Eleva GmbH
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Kentucky Bioprocessing, LLC
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Solarvest Bioenergy Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Byondis B.V.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About Us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們